Document:

<PAGE>
                                                                    Exhibit 10.8
                               CONSULTANT AGREEMENT

Consultant Agreement, between Aquatic Cellulose (the "Company") and Les
Westgarde (the " Consultant ").

1. For good consideration, the Company employs the consultant on the following
terms and conditions.

2. TERM OF EMPLOYMENT. Subject to the provisions for termination set forth below
this agreement will begin on Oct 1, 2006.

3. SALARY. The Company shall pay a salary of $5000 per month, for the services
of the Consultant, payable by monthly for three months commencing October 1,
2006 to Dec 31, 2006. After which, at the Company's option to renew this
contract may have option to pay the Consultant 80% in cash and 20% in stock for
services rendered.

4. VACATION. The Consultant shall be entitled to a yearly vacation of 3 weeks at
full pay.

5. DUTIES AND POSITION. The Company hires the Consultant in the capacity of
office administration and the Consultants duties may be reasonably modified at
the Company's discretion from time to time.

6. CONFIDENTIALITY OF PROPRIETARY INFORMATION. Consultant agrees, during the
term of this employment, not to reveal confidential information, or trade
secrets to any person, firm, corporation, or entity. Should Consultant reveal or
threaten to reveal this information, the Company shall be entitled to an
injunction restraining the Consultant from disclosing same, or from rendering
any services to any entity to whom said information has been or is threatened to
be disclosed, the right to secure an injunction is not exclusive, and the
Company may pursue any other remedies it has against the Consultant for a breach
or threatened breach of this condition, including the recovery of damages from
the Consultant.

7. REIMBURSEMENT OF EXPENSES. The Consultant may incur reasonable expenses for
furthering the Company's business, including expenses for entertainment, travel,
and similar items. The Company shall reimburse Consultant for all business
expenses after the Consultant presents an itemized account of expenditures,
pursuant to Company policy.

8. TERMINATION OF AGREEMENT. Without cause, if the Company terminates this
agreement at any time, the Company will pay the Consultant on the date of the
termination a severance allowance of 3 months Salary

9. SETTLEMENT BY ARBITRATION. Any claim or controversy that arises out of or
relates to this agreement, or the breach of it, shall be settled by arbitration
in accordance with the rules of the American Arbitration Association. Judgment
upon the award rendered may be entered in any court with jurisdiction.

10. ASSUMPTION OF AGREEMENT BY COMPANY'S SUCCESSORS AND ASSIGNEES. The Company's
rights and obligations under this agreement will inure to the benefit and be
binding upon the Company's successors and assignees.

SIGNED THIS 01 DAY OF OCTOBER, 2006

/S/ SHERIDAN B. WESTGARDE                   /S/ LES W. WESTGARDE
-------------------------                   --------------------
President                                   ConsultantFirmInvest, AG private placement offer letter

 Exhibit 10.1 
  
 [LOGO OF FIRMINVEST AG] 
 May 20, 2007 
 Dr. Thomas Stegmann & Daniel Montano, Co-Presidents 
 CardioVascular
BioTherapeutics, Inc. 
 Gentlemen: 
 This letter is a
commitment letter of Firminvest AG (whose principals are longstanding shareholders of CVBT) and its affiliates to subscribe to 100% of the CardioVascular BioTherapeutics, Inc. Reg-S offering of 15,000,000 shares of common stock at $1.00 per
share. 
 Firminvest AG will make a payment of 1,500,000 US$ by May 24, 2007, as a Good Faith commitment. An additional $1,500,000 by May 31, 2007, and the
balance of $12,000,000 by June 29, 2007. 
 Firminvest AG will have the right to allocate the exact number of shares between its affiliates. 
 This offer is good for two days only and expires at the close of business, 5 p.m., Las Vegas time, May 21, 2007. 
 Verbal notification of acceptance by CardioVascular BioTherapeutic’s Board of Directors is acceptable. Written acceptance by the CVBT board must be received before
the first $1,500,000 is transferred to CardioVascular BioTherapeutics. 
 Sincerely, 
 /s/    FREDERICK CHANSON 
 Frederic Chanson 
 Chairman & CEO, Firminvest AG 
  
 ACCEPTANCE: The undersigned hereby represents and warrants he has read and accepts the above terms and has received approval from the Board of Directors of CardioVascular BioTherapeutics, Inc. to enter into the
transactions as set forth above. 
  

							
	 /s/    DANIEL C. MONTANO
	  	 May 21, 2007
	  	 13:20
	  	(PST)
	Daniel C. Montano	  	Date	  	Time	  	
	Chief Executive Officer	  		  		  	

 Postfach 1718 • Stockerstrasse 48 • 8027 Zürich • Telefon +41 44 288 36 36
• Fax +41 44 288 36 11Second Supplemental Indenture with respect to the 8 7/8% Senior Notes due 2016

 Exhibit 4.3 
 SECOND SUPPLEMENTAL INDENTURE 
 SECOND SUPPLEMENTAL INDENTURE (this “Second Supplemental
Indenture”) dated as of April 1, 2007, among ZURN INDUSTRIES, LLC, a Delaware limited liability company (“Zurn LLC”), an indirect subsidiary of RBS GLOBAL, INC. (or its successor), a Delaware corporation (the
“Company”), REXNORD, LLC, a Delaware limited liability company, (“Rexnord” and, together with the Company, the “Issuers”) and WELLS FARGO BANK, NATIONAL ASSOCIATION, a national banking association, as
trustee under the indenture referred to below (the “Trustee”). 
 WITNESSETH: 
 WHEREAS, the Issuers and the existing Guarantors have heretofore executed and delivered to the Trustee an indenture (as amended, supplemented or
otherwise modified, the “Indenture”) dated as of February 7, 2007, providing for the issuance of the Issuers’ 8 7/8% Senior Notes due 2016 (the “Securities”), initially in the aggregate principal amount of $150,000,000;

 WHEREAS, Zurn Industries, Inc., a Pennsylvania corporation (“Zurn Industries”), executed that certain First Supplemental
Indenture dated February 7, 2007, pursuant to which it unconditionally guaranteed the Issuers’ Obligations under the Notes and the Indenture; 
 WHEREAS, Zurn Industries merged with and into its wholly-owned subsidiary, Zurn Delaware Corp., a Delaware corporation (“Zurn DE”), which was incorporated solely for the purpose of reincorporating
Zurn Industries in the State of Delaware, said merger being permitted pursuant to Section 5.01(b) of the Indenture; 
 WHEREAS,
Zurn DE has converted to a limited liability company organized under the laws of the State of Delaware known as Zurn Industries, LLC (“Zurn LLC”); 
 WHEREAS, Section 5.01(b) of the Indenture permits the Company to allow a Guarantor to sell, assign, transfer, lease, convey or otherwise dispose of all or substantially all of its properties or assets in
one or more related transactions to any Person provided, among other things, such Person expressly assumes all the obligations of such Guarantor under the Indenture and such Guarantor’s Guarantee pursuant to a supplemental indenture or other
documents or instruments in form reasonably acceptable to the Trustee; 
 WHEREAS, Zurn LLC is willing to execute and deliver this
Second Supplemental Indenture to ensure compliance with Section 5.01(b) of the Indenture with respect to Zurn DE’s conversion; and 
 WHEREAS, pursuant to Section 9.01 of the Indenture, the Trustee, the Issuers and Zurn LLC are authorized to execute and deliver this Second Supplemental Indenture; 
  

 1 

 NOW, THEREFORE, in consideration of the foregoing and for other good and valuable consideration,
the receipt of which is hereby acknowledged, Zurn LLC, the Issuers and the Trustee mutually covenant and agree for the equal and ratable benefit of the holders of the Securities as follows: 
 1. Defined Terms. As used in this Second Supplemental Indenture, terms defined in the Indenture or in the preamble or recital hereto are used
herein as therein defined, except that the term “Holders” in this Guarantee shall refer to the term “Holders” as defined in the Indenture and the Trustee acting on behalf of and for the benefit of such Holders. The words
“herein,” “hereof” and “hereby” and other words of similar import used in this Second Supplemental Indenture refer to this Second Supplemental Indenture as a whole and not to any particular section hereof. 

2. Assumption of Obligations. Zurn LLC hereby expressly assumes all the obligations of Zurn DE (as the surviving corporation of the merger of
Zurn Industries with and into Zurn DE) under the Indenture and the Guarantee of Zurn DE (as the surviving corporation of the merger of Zurn Industries with and into Zurn DE). 
 3. Notices. All notices or other communications to Zurn LLC shall be given as provided in Section 13.02 of the Indenture. 
 4. Ratification of Indenture; Second Supplemental Indenture Part of Indenture. Except as expressly amended hereby, the Indenture is in all
respects ratified and confirmed and all the terms, conditions and provisions thereof shall remain in full force and effect. This Second Supplemental Indenture shall form a part of the Indenture for all purposes, and every holder of Securities
heretofore or hereafter authenticated and delivered shall be bound hereby. 
 5. Governing Law. THIS SECOND SUPPLEMENTAL INDENTURE
SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK, WITHOUT REGARD TO PRINCIPLES OF CONFLICTS OF LAW. 
 6. Trustee Makes No Representation. The Trustee makes no representation as to the validity or sufficiency of this Second Supplemental Indenture. 
 7. Counterparts. The parties may sign any number of copies of this Second Supplemental Indenture. Each signed copy shall be an original, but all of them together represent the same agreement. 
 8. Effect of Headings. The Section headings herein are for convenience only and shall not effect the construction thereof. 
  

 2 

 IN WITNESS WHEREOF, the parties hereto have caused this Second Supplemental Indenture to be duly
executed as of the date first above written. 
  

			
	ZURN INDUSTRIES, LLC
		
	By:	 	 /s/ George C. Moore

	Name:	 	George C. Moore
	Title:	 	Executive Vice President and
		 	Chief Financial Officer
	
	RBS GLOBAL, INC.
		
	By:	 	 /s/ George C. Moore

	Name:	 	George C. Moore
	Title:	 	Executive Vice President and
		 	Chief Financial Officer
	
	REXNORD, LLC
		
	By:	 	 /s/ George C. Moore

	Name:	 	George C. Moore
	Title:	 	Executive Vice President and
		 	Chief Financial Officer
	
	WELLS FARGO BANK, NATIONAL ASSOCIATION, AS TRUSTEE
		
	By:	 	  

	Name:	 	  

	Title:	 	  

  

 3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00124-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00124-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00124-of-00352.parquet"}]]